Eli Lilly and Co (LLY.N)
|Market Cap (Mil.):||$74,377.11|
|Shares Outstanding (Mil.):||1,113.43|
- Eli Lilly and Co and German drugmaker Boehringer Ingelheim said they had revised the structure of their diabetes alliance for some countries.
Oct 29 - Eli Lilly and Co and German drugmaker Boehringer Ingelheim said they had revised the structure of their diabetes alliance for some countries.
- A U.S. judge on Monday slashed a $9 billion punitive damages award to $36.8 million against Takeda Pharmaceutical Co and Eli Lilly & Co over their Actos diabetes drug, although she rejected their request for a new trial.
NEW YORK, Oct 27 - A U.S. judge on Monday slashed a $9 billion punitive damage award against Takeda Pharmaceutical Co and Eli Lilly & Co over their Actos diabetes drug to $36.8 million, according to a court filing.
* Agrees to acquire veterinary assets from Eli Lilly in United States
- Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its full-year profit forecast.
BAD VILBEL Germany - Germany's Stada plans to bring a copy of Eli Lilly's Forteo osteoporosis treatment to market, its chief executive said, as the generic drugmaker moves further into the sale of cheaper alternatives for costly biotech drugs.
BRUSSELS, Oct 3 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
BRUSSELS - EU antitrust regulators approved U.S. drugmaker Eli Lilly's $5.4 billion takeover of Swiss peer Novartis's animal health business on Friday.
BRUSSELS, Oct 3 - EU antitrust regulators approved U.S. drugmaker Eli Lilly's $5.4 billion takeover of Swiss peer Novartis's animal health business on Friday.
|Takeda Pharmaceutical Co Ltd (4502.T)||¥4,804||+147.00|
|Johnson & Johnson (JNJ.N)||$107.39||+0.35|
|Pfizer Inc. (PFE.N)||$29.85||+0.01|
|Novartis AG (NOVN.VX)||CHF89.30||+1.60|
|Merck & Co., Inc. (MRK.N)||$57.74||+0.44|
|Abbott Laboratories (ABT.N)||$43.47||-0.02|
|Sanofi SA (SASY.PA)||€73.66||+1.75|
|AstraZeneca plc (AZN.L)||4,543.50p||+43.50|
|GlaxoSmithKline plc (GSK.L)||1,417.50p||+19.50|
|Bristol-Myers Squibb Co (BMY.N)||$57.66||-1.32|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (LLY). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
"The Economy Matters" Report for LLY: the economy's impact on LLY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Thomson Reuters Stock Report
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.